US3843662A
(en)
|
1971-12-09 |
1974-10-22 |
Pfizer |
2-halo-5-(substituted piperidino sulfonyl)benzoic acids
|
AU1508183A
(en)
|
1982-06-04 |
1983-12-08 |
Beecham Group Plc |
Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane
|
WO1984003281A1
(en)
|
1983-02-19 |
1984-08-30 |
Beecham Group Plc |
Azabicycloalkyl benzamide and anilide derivatives
|
JPS62142164A
(en)
|
1985-12-13 |
1987-06-25 |
Ishihara Sangyo Kaisha Ltd |
4,5-dichloroimidazole based compound and pest controlling agent containing said compound
|
IN164880B
(en)
|
1986-01-30 |
1989-06-24 |
Ishihara Sangyo Kaisha |
|
US5272167A
(en)
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
CA1339133C
(en)
|
1987-03-13 |
1997-07-29 |
Rikuo Nasu |
Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
|
US5571821A
(en)
|
1993-05-20 |
1996-11-05 |
Texas Biotechnology Corporation |
Sulfonamides and derivatives thereof that modulate the activity of endothelin
|
GB8904174D0
(en)
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
US4962101A
(en)
|
1989-08-21 |
1990-10-09 |
Merck & Co., Inc. |
2-(Heterocyclylalkyl)phenyl carbapenem antibacterial agents
|
GB9023082D0
(en)
|
1990-10-24 |
1990-12-05 |
Schering Agrochemicals Ltd |
Fungicides
|
GB9109557D0
(en)
|
1991-05-02 |
1991-06-26 |
Wellcome Found |
Chemical compounds
|
US5308826A
(en)
|
1993-04-22 |
1994-05-03 |
Zeneca Limited |
Herbicidal 4-substituted pyridyl-3-carbinols
|
GB9405347D0
(en)
|
1994-03-18 |
1994-05-04 |
Agrevo Uk Ltd |
Fungicides
|
WO1995032949A1
(en)
|
1994-05-27 |
1995-12-07 |
James Black Foundation Limited |
Gastrin and cck antagonists
|
US5795907A
(en)
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
US5763618A
(en)
|
1995-05-12 |
1998-06-09 |
Konica Corporation |
Manufacturing method of sulfides
|
US5723411A
(en)
|
1995-10-31 |
1998-03-03 |
E. I. Du Pont De Nemours And Company |
Herbicidal pyridazinones
|
DE19540995A1
(en)
|
1995-11-03 |
1997-05-07 |
Hoechst Ag |
Substituted sulfonimidamides, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
|
GB9612884D0
(en)
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
EP0912550A1
(en)
|
1996-06-25 |
1999-05-06 |
Smithkline Beecham Plc |
Sulfonamide derivatives as 5ht7 receptor antagonists
|
WO1998023285A1
(en)
|
1996-11-29 |
1998-06-04 |
Smithkline Beecham Plc |
Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis b
|
US5939423A
(en)
|
1997-04-16 |
1999-08-17 |
Sciclone Pharmaceuticals, Inc. |
Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
|
US5919970A
(en)
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
EP1741424B1
(en)
|
1997-08-11 |
2018-10-03 |
Pfizer Products Inc. |
Solid pharmaceutical dispersions with enhanced bioavailabilty
|
US5994396A
(en)
|
1997-08-18 |
1999-11-30 |
Centaur Pharmaceuticals, Inc. |
Furansulfonic acid derivatives and pharmaceutical compositions containing the same
|
CA2318731C
(en)
|
1998-01-29 |
2012-05-29 |
Tularik Inc. |
Ppar-gamma modulators
|
US6410561B1
(en)
|
1998-03-26 |
2002-06-25 |
Japan Tobacco Inc. |
Amide derivatives and nociceptin antagonists
|
US6251893B1
(en)
|
1998-06-15 |
2001-06-26 |
Nps Allelix Corp. |
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
|
EP1650193A3
(en)
|
1999-01-15 |
2006-10-04 |
ALTANA Pharma AG |
6-Phenylphenanthridines with PDE-IV inhibiting activity
|
ATE400251T1
(en)
|
1999-02-09 |
2008-07-15 |
Pfizer Prod Inc |
COMPOSITIONS OF BASIC DRUGS WITH IMPROVED BIOAVAILABILITY
|
WO2001005390A2
(en)
|
1999-07-16 |
2001-01-25 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
US7816560B1
(en)
|
1999-08-10 |
2010-10-19 |
Thomas Jefferson University |
Long chain n-alkyl compounds and oxa-derivatives thereof
|
WO2001019788A2
(en)
|
1999-09-17 |
2001-03-22 |
Cor Therapeutics, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
PE20010628A1
(en)
|
1999-10-01 |
2001-06-18 |
Takeda Chemical Industries Ltd |
CYCLIC AMINE COMPOUNDS, THEIR PRODUCTION AND THEIR USE
|
EP1738749A1
(en)
|
1999-12-23 |
2007-01-03 |
Pfizer Products Inc. |
Pharmaceutical compositions providing enhanced drug concentrations
|
BR0016818A
(en)
|
1999-12-28 |
2002-10-01 |
Pfizer Prod Inc |
Non-peptidyl inhibitors of vla-4-dependent cell adhesion useful in the treatment of inflammatory, autoimmune and respiratory diseases
|
WO2001055121A1
(en)
|
2000-01-28 |
2001-08-02 |
Kaken Pharmaceutical Co., Ltd. |
Azepine derivatives
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
EP1193268A1
(en)
|
2000-09-27 |
2002-04-03 |
Applied Research Systems ARS Holding N.V. |
Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
|
WO2002051410A2
(en)
|
2000-12-22 |
2002-07-04 |
Akzo Nobel N.V. |
Phenylthiazole and thiazoline derivatives and their use as antiparasitics
|
JPWO2002053566A1
(en)
|
2000-12-27 |
2004-05-13 |
住友製薬株式会社 |
New carbapenem compounds
|
AU2002248418A1
(en)
|
2001-02-09 |
2002-08-28 |
Massachusetts Institute Of Technology |
Methods of identifying agents that mediate polypeptide aggregation
|
US6650463B2
(en)
|
2001-03-13 |
2003-11-18 |
Seiko Epson Corporation |
Electrophoretic display device
|
JP2005500314A
(en)
|
2001-06-21 |
2005-01-06 |
ファイザー・プロダクツ・インク |
Self-emulsifying formulation of cholesterol ester transfer protein inhibitor
|
EP1269994A3
(en)
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
SE0102315D0
(en)
|
2001-06-28 |
2001-06-28 |
Astrazeneca Ab |
Compounds
|
KR100713137B1
(en)
|
2001-06-28 |
2007-05-02 |
동화약품공업주식회사 |
Novel 2,4-difluorobenzamide derivatives
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
DE10136043A1
(en)
|
2001-07-25 |
2003-02-13 |
Degussa |
Process for the production of modified carbon black
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
WO2003044016A1
(en)
|
2001-11-20 |
2003-05-30 |
Eli Lilly And Company |
3-SUBSTITUTED OXINDOLE β3 AGONISTS
|
MXPA04007428A
(en)
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Immediate release dosage forms containing solid drug dispersions.
|
RS61604A
(en)
|
2002-02-01 |
2006-10-27 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
AU2003239463B2
(en)
|
2002-02-01 |
2007-10-18 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
SE0201635D0
(en)
|
2002-05-30 |
2002-05-30 |
Astrazeneca Ab |
Novel compounds
|
EA009523B1
(en)
|
2002-06-05 |
2008-02-28 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Inhibitors against the activation of ap-1 and nfat
|
BR0312023A
(en)
|
2002-06-27 |
2005-03-22 |
Novo Nordisk As |
Compound, glucose kinase activating compound, method for preventing hypoglycemia, use of a compound, and pharmaceutical composition
|
CN1678311A
(en)
|
2002-06-27 |
2005-10-05 |
诺沃挪第克公司 |
Aryl carbonyl derivatives as therapeutic agents
|
AU2003254177A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
WO2004010943A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
US7338956B2
(en)
|
2002-08-07 |
2008-03-04 |
Sanofi-Aventis Deutschland Gmbh |
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
|
US7186735B2
(en)
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
JP4399862B2
(en)
|
2002-08-09 |
2010-01-20 |
味の素株式会社 |
Treatment for bowel disease and visceral pain
|
US20040110802A1
(en)
|
2002-08-23 |
2004-06-10 |
Atli Thorarensen |
Antibacterial benzoic acid derivatives
|
BR0314059A
(en)
|
2002-09-06 |
2005-07-05 |
Janssen Pharmaceutica Nv |
Heterocyclic compounds
|
SE0202838D0
(en)
|
2002-09-24 |
2002-09-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2004058709A1
(en)
|
2002-12-23 |
2004-07-15 |
Millennium Pharmaceuticals, Inc. |
Ccr8 inhibitors
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
US7595322B2
(en)
|
2003-03-27 |
2009-09-29 |
Cytokinetics, Inc. |
Heterocyclic sulfonamides as modulators of cardiac sarcomeres
|
EP1628970A2
(en)
|
2003-04-30 |
2006-03-01 |
The Institutes of Pharmaceutical Discovery, LLC |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
EP1620094A4
(en)
|
2003-05-06 |
2010-04-28 |
Glaxosmithkline Llc |
Novel chemical compounds
|
WO2004101562A2
(en)
|
2003-05-13 |
2004-11-25 |
Schering Corporation |
Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
|
EP1651595A2
(en)
|
2003-05-30 |
2006-05-03 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
US20110275630A1
(en)
|
2003-06-02 |
2011-11-10 |
Abbott Laboratories |
Isoindolinone kinase inhibitors
|
JP2006527201A
(en)
|
2003-06-06 |
2006-11-30 |
スミスクライン・ビーチャム・コーポレイション |
IL-8 receptor antagonist
|
AR045047A1
(en)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
|
GB0319151D0
(en)
|
2003-08-14 |
2003-09-17 |
Glaxo Group Ltd |
Novel compounds
|
WO2005026129A1
(en)
|
2003-09-15 |
2005-03-24 |
Gpc Biotech Ag |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7498050B2
(en)
|
2003-12-15 |
2009-03-03 |
Kraft Foods Global Brands Llc |
Edible spread composition and packaged product
|
DE102004009238A1
(en)
|
2004-02-26 |
2005-09-08 |
Merck Patent Gmbh |
New aryl amide compounds are kinase inhibitors useful for the treatment and/or prophylaxis of e.g. tumors, psoriasis, rheumatoid arthritis, contact dermatitis, inflammations, endometriosis, scar and benign prostatic hyperplasia
|
US8404747B2
(en)
|
2004-03-05 |
2013-03-26 |
The General Hospital Corporation |
Compositions and methods for modulating interaction between polypeptides
|
EP1758856A2
(en)
|
2004-05-04 |
2007-03-07 |
Novo Nordisk A/S |
Indole derivatives for the treatment of obesity
|
CA2568007A1
(en)
|
2004-05-28 |
2005-12-08 |
Pfizer Products Inc. |
Pharmaceutical compositions with enhanced performance
|
WO2005115374A1
(en)
|
2004-05-29 |
2005-12-08 |
7Tm Pharma A/S |
Crth2 receptor ligands for therapeutic use
|
MX2007000015A
(en)
|
2004-06-22 |
2007-03-07 |
Schering Corp |
Cannabinoid receptor ligands.
|
PL1773768T3
(en)
|
2004-07-30 |
2019-03-29 |
Exelixis, Inc. |
Pyrrole derivatives as pharmaceutical agents
|
DE102004042441A1
(en)
|
2004-08-31 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Amino acid substituted hexahydro-pyrazino (1,2-a) pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
|
KR20070048798A
(en)
|
2004-08-31 |
2007-05-09 |
아스트라제네카 아베 |
Quinazolinone derivatives and their use as b-raf inhibitors
|
KR20070084067A
(en)
|
2004-10-13 |
2007-08-24 |
와이어쓰 |
N-benzenesulfonyl substituted anilino-pyrimidine analogs
|
RU2007118523A
(en)
|
2004-10-19 |
2008-11-27 |
Новартис Вэксинс Энд Диагностикс Инк. (Us) |
DERIVATIVES OF INDOL AND BENZIMIDAZOLE
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
US20060122236A1
(en)
|
2004-12-06 |
2006-06-08 |
Wood Michael R |
Substituted biaryl-carboxylate derivatives
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
CA2589773A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
FI117653B
(en)
|
2005-02-21 |
2006-12-29 |
Eigenor Oy |
Procedure and arrangement for sensing objects with a radar
|
US9713592B2
(en)
|
2005-04-06 |
2017-07-25 |
Mallinckrodt Llc |
Matrix-based pulse release pharmaceutical formulation
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
US7790726B2
(en)
|
2005-08-16 |
2010-09-07 |
Chemocentryx, Inc. |
Monocyclic and bicyclic compounds and methods of use
|
KR20080050490A
(en)
|
2005-09-16 |
2008-06-05 |
애로우 쎄라퓨틱스 리미티드 |
Biphenyl derivatives and their use in treating hepatitis c
|
CA2633541A1
(en)
|
2005-12-12 |
2007-06-21 |
Genelabs Technologies, Inc. |
N-(6-membered aromatic ring)-amido anti-viral compounds
|
JP2009521452A
(en)
|
2005-12-21 |
2009-06-04 |
シェーリング コーポレイション |
Treatment of nonalcoholic fatty liver disease using cholesterol-lowering agents and H3 receptor antagonists / inverse agonists
|
WO2007073935A1
(en)
|
2005-12-29 |
2007-07-05 |
Lek Pharmaceuticals D.D. |
Heterocyclic compounds
|
CN101437824B
(en)
|
2006-05-04 |
2013-03-13 |
肝炎与病毒研究所 |
Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus
|
US20080021063A1
(en)
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
FR2903985B1
(en)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
N- (AMINO-HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
|
FR2904316B1
(en)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
N- (AMINO-HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
|
WO2008022171A1
(en)
|
2006-08-17 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors
|
EP2076492A4
(en)
|
2006-10-06 |
2010-12-22 |
Merck Sharp & Dohme |
Non-nucleoside reverse transcriptase inhibitors
|
EP2101741B1
(en)
|
2006-10-17 |
2010-08-11 |
Bend Research, Inc. |
Solid dispersion comprising a poorly water soluble drug
|
WO2008076270A2
(en)
|
2006-12-13 |
2008-06-26 |
Temple University-Of The Commonwealth System Of Higher Education |
Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
US20100022517A1
(en)
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
FR2910473B1
(en)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
N- (AMINO-HETEROARYL) -1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
|
JP2008179621A
(en)
|
2006-12-28 |
2008-08-07 |
Taisho Pharmaceutical Co Ltd |
Nitrogen-containing saturated heterocyclic compound
|
JP2008184403A
(en)
|
2007-01-29 |
2008-08-14 |
Japan Health Science Foundation |
New hepatitis c virus inhibitor
|
AR065718A1
(en)
|
2007-03-15 |
2009-06-24 |
Novartis Ag |
NITROGEN HETEROCICLICAL COMPOUNDS, USEFUL IN THE DIAGNOSIS AND TREATMENT OF HYPERPROLIFERATIVE DISORDERS.
|
US8097728B2
(en)
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
CA2686382C
(en)
|
2007-05-04 |
2013-09-17 |
Irm Llc |
Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
|
CN101328169B
(en)
|
2007-06-18 |
2011-05-25 |
张中能 |
Diethylcarbamyl-substituted thiazole dihydropyrimidine
|
WO2009018219A2
(en)
|
2007-07-28 |
2009-02-05 |
University Of Chicago |
Methods and compositions for modulating rad51 and homologous recombination
|
JP2010535172A
(en)
|
2007-08-02 |
2010-11-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
Use of benzamide derivatives for the treatment of CNS disorders
|
CN101429166B
(en)
|
2007-11-07 |
2013-08-21 |
上海特化医药科技有限公司 |
Quinazoline ketone derivant, preparation method and application thereof
|
CA2704645A1
(en)
|
2007-11-09 |
2009-05-14 |
The Salk Institute For Biological Studies |
Non-nucleoside reverse transcriptase inhibitors
|
JP2011507910A
(en)
|
2007-12-21 |
2011-03-10 |
ユニバーシティー オブ ロチェスター |
Methods for changing the lifetime of eukaryotes
|
FR2926554B1
(en)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
AZABICYCLIC CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
|
FR2926555B1
(en)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
BICYCLIC DERIVATIVES OF AZABICYCLIC CARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
|
FR2926556B1
(en)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
N-AZABICYCLIC CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
|
FR2926553B1
(en)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
SILANYL SUBSTITUTED INDOLE-2-CARBOXAMIDE AND AZAINDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
|
CU20080028A6
(en)
|
2008-02-29 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
CHEMICAL COMPOUNDS OBTAINED IN SILICO FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS TO ATTENE OR INHIBIT INFECTION BY DENGUE VIRUSES AND OTHER FLAVIVIRUS
|
WO2009146013A1
(en)
|
2008-03-31 |
2009-12-03 |
Georgetown University |
Myosin light chain phosphatase inhibitors
|
JP5501226B2
(en)
|
2008-04-24 |
2014-05-21 |
Msd株式会社 |
Long-chain fatty acid elongation enzyme inhibitor comprising an arylsulfonyl derivative as an active ingredient
|
US20100008968A1
(en)
|
2008-06-26 |
2010-01-14 |
Lampe John W |
Method for treating cardiovascular diseases using rho kinase inhibitor compounds
|
US20090325959A1
(en)
|
2008-06-26 |
2009-12-31 |
Vittitow Jason L |
Method for treating ophthalmic diseases using rho kinase inhibitor compounds
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
US20090325960A1
(en)
|
2008-06-26 |
2009-12-31 |
Fulcher Emilee H |
Method for treating inflammatory diseases using rho kinase inhibitor compounds
|
EP2317849A4
(en)
|
2008-06-26 |
2011-11-02 |
Inspire Pharmaceuticals Inc |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
US8410147B2
(en)
|
2008-06-26 |
2013-04-02 |
Inspire Pharmaceuticals, Inc. |
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
|
JP2012500189A
(en)
|
2008-08-15 |
2012-01-05 |
エフ.ホフマン−ラ ロシュ アーゲー |
Biarylaminotetralin
|
US9040488B2
(en)
|
2008-09-02 |
2015-05-26 |
Baruch S. Blumberg Institute |
Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
|
US8143269B2
(en)
|
2008-10-03 |
2012-03-27 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
WO2010043592A1
(en)
|
2008-10-15 |
2010-04-22 |
Revotar Biopharmaceuticals Ag |
Lipase inhibitors for use for the treatment of obesity
|
US8697685B2
(en)
|
2008-11-20 |
2014-04-15 |
Glaxosmithkline Llc |
Chemical compounds
|
EP2400969A4
(en)
|
2008-12-04 |
2012-05-16 |
Inspire Pharmaceuticals Inc |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
WO2010078430A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
|
WO2010088000A2
(en)
|
2009-02-02 |
2010-08-05 |
Angion Biomedica Corp. |
Antifibrotic compounds and uses thereof
|
WO2010123139A1
(en)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
Arylcarboxamide derivative having sulfamoyl group
|
EP2432762B8
(en)
|
2009-05-19 |
2015-04-08 |
Bayer Intellectual Property GmbH |
Insecticidal arylpyrrolines
|
CN106167488A
(en)
|
2009-05-27 |
2016-11-30 |
Ptc医疗公司 |
Treatment cancer and the method for non-neoplastic conditions
|
WO2011002635A1
(en)
|
2009-06-30 |
2011-01-06 |
Siga Technologies, Inc. |
Treatment and prevention of dengue virus infections
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2011035143A2
(en)
|
2009-09-17 |
2011-03-24 |
The Regents Of The University Of Michigan |
Methods and compositions for inhibiting rho-mediated diseases and conditions
|
BR112012008865A2
(en)
*
|
2009-10-16 |
2019-09-24 |
Glaxo Group Ltd |
antisense hbv inhibitors.
|
WO2011058766A1
(en)
|
2009-11-16 |
2011-05-19 |
Raqualia Pharma Inc. |
Aryl carboxamide derivatives as ttx-s blockers
|
CN102093320B
(en)
|
2009-12-09 |
2013-08-28 |
扬子江药业集团上海海尼药业有限公司 |
Soluble epoxide hydrolase inhibitor
|
JP2013517271A
(en)
|
2010-01-15 |
2013-05-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Compounds that modulate the CB2 receptor
|
WO2011088561A1
(en)
|
2010-01-20 |
2011-07-28 |
University Of Manitoba |
Anti-viral compounds and compositions
|
WO2011109237A2
(en)
|
2010-03-02 |
2011-09-09 |
Emory University |
Uses of noscapine and derivatives in subjects diagnosed with fap
|
EP2545042A1
(en)
|
2010-03-11 |
2013-01-16 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
CN102206172B
(en)
|
2010-03-30 |
2015-02-25 |
中国医学科学院医药生物技术研究所 |
Substituted diaryl compound and preparation method and antiviral application thereof
|
JP2013523766A
(en)
|
2010-03-31 |
2013-06-17 |
グラクソ グループ リミテッド |
Imidazolyl-imidazole as a kinase inhibitor
|
US8536179B2
(en)
|
2010-05-07 |
2013-09-17 |
Glaxosmithkline Llc |
Indoles
|
US8993622B2
(en)
|
2010-06-11 |
2015-03-31 |
Eirium Ab |
Antiviral compounds
|
US9040033B2
(en)
|
2010-06-14 |
2015-05-26 |
Dow Global Technologies Llc |
Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
|
US20130142827A1
(en)
|
2010-06-25 |
2013-06-06 |
Philadelphia Health & Education Corporation D/B/A |
Induction of immune response
|
EP2595665A1
(en)
|
2010-07-19 |
2013-05-29 |
Inspire Pharmaceuticals, Inc. |
Bifunctional rho kinase inhibitor compounds, composition and use
|
CA2806664A1
(en)
|
2010-07-26 |
2012-02-09 |
Neurotherapeutics Pharma, Inc. |
Arylsulfonamide derivatives, compositions, and methods of use
|
MX2013001003A
(en)
|
2010-07-27 |
2013-03-07 |
Inspire Pharmaceuticals Inc |
Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms.
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
WO2012033956A1
(en)
|
2010-09-08 |
2012-03-15 |
Mithridion, Inc. |
Cognition enhancing compounds and compositions, methods of making, and methods of treating
|
EP2624837A4
(en)
|
2010-10-04 |
2014-03-26 |
Inst Hepatitis & Virus Res |
Novel inhibitors of secretion of hepatitis b virus antigens
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
EP2646439B1
(en)
|
2010-12-02 |
2016-05-25 |
Bristol-Myers Squibb Company |
Alkyl amides as hiv attachment inhibitors
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
GB201103419D0
(en)
|
2011-02-28 |
2011-04-13 |
Univ Aberdeen |
|
BR112013025987B1
(en)
|
2011-04-08 |
2021-04-06 |
Janssen Sciences Ireland Uc |
PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND USE OF THE SAME
|
US8889716B2
(en)
|
2011-05-10 |
2014-11-18 |
Chdi Foundation, Inc. |
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
WO2013006394A1
(en)
|
2011-07-01 |
2013-01-10 |
Institute For Hepatitis And Virus Research |
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
|
CA2857344C
(en)
|
2011-12-21 |
2019-02-12 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
EP2800742B1
(en)
|
2012-01-06 |
2016-04-06 |
Janssen Sciences Ireland UC |
4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b
|
EP2819671A4
(en)
|
2012-02-29 |
2016-05-11 |
Baruch S Blumberg Inst |
Binhibitors of hepatitis b virus convalently closed circular dna formation and their method of use
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
MX2014011749A
(en)
|
2012-03-31 |
2015-01-22 |
Hoffmann La Roche |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection.
|
CA2871547C
(en)
|
2012-05-25 |
2021-05-25 |
Janssen R&D Ireland |
Uracyl spirooxetane nucleosides
|
KR101945578B1
(en)
|
2012-06-01 |
2019-02-07 |
드렉셀유니버시티 |
Modulation of hepatitis b virus cccdna transcription
|
JO3300B1
(en)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
Compounds and compositions for modulating egfr activity
|
TW201408652A
(en)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
Aryl sultam derivatives as RORc modulators
|
NZ743499A
(en)
|
2012-08-28 |
2019-09-27 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
DK2890683T3
(en)
|
2012-08-28 |
2017-01-30 |
Janssen Sciences Ireland Uc |
MERGED BICYCLIC SULFAMOYL DERIVATIVES AND THEIR USE AS MEDICINES TO TREAT HEPATITIS B
|
CA2881322A1
(en)
|
2012-09-10 |
2014-03-13 |
F. Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
CA2896554C
(en)
|
2012-12-27 |
2019-11-05 |
Drexel University |
Novel antiviral agents against hbv infection
|
JP6396333B2
(en)
|
2013-02-12 |
2018-09-26 |
ベンド・リサーチ・インコーポレーテッドBend Research,Incorporated |
Solid dispersion of low water-soluble active substances
|
US9458176B2
(en)
|
2013-02-28 |
2016-10-04 |
Eisai R&D Management Co., Ltd. |
Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative
|
EA027194B1
(en)
|
2013-02-28 |
2017-06-30 |
Янссен Сайенсиз Айрлэнд Юси |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
BR112015019807B1
(en)
|
2013-03-07 |
2020-12-08 |
Dow Global Technologies Llc |
hydroxypropyl methylcellulose succinate, composition, solid dispersion, dosage form and capsule wrap
|
US8993771B2
(en)
|
2013-03-12 |
2015-03-31 |
Novira Therapeutics, Inc. |
Hepatitis B antiviral agents
|
US9944658B2
(en)
|
2013-03-14 |
2018-04-17 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
BR112015025052A2
(en)
|
2013-04-03 |
2021-07-06 |
Janssen Sciences Ireland Uc |
n-phenyl carboxamide derivatives and their use as medicines for the treatment of hepatitis b
|
WO2014184328A1
(en)
|
2013-05-17 |
2014-11-20 |
F. Hoffmann-La Roche Ag |
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
JO3603B1
(en)
*
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
EP2997019B1
(en)
|
2013-05-17 |
2018-08-08 |
Janssen Sciences Ireland UC |
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
CN105744838B
(en)
|
2013-05-28 |
2017-12-08 |
拜耳作物科学股份公司 |
Heterocyclic compound as agricultural chemicals
|
CN105229004B
(en)
|
2013-05-28 |
2017-05-03 |
阿斯利康(瑞典)有限公司 |
Chemical compounds
|
WO2014198880A1
(en)
|
2013-06-14 |
2014-12-18 |
Ferrer Internacional, S.A. |
2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
|
TR201807090T4
(en)
|
2013-07-25 |
2018-06-21 |
Janssen Sciences Ireland Uc |
Glyoxamide substituted pyrrolamide derivatives and its use as medicaments for the treatment of hepatitis.
|
WO2015055764A1
(en)
|
2013-10-18 |
2015-04-23 |
Syngenta Participations Ag |
3-methanimidamid-pyridine derivatives as fungicides
|
AU2014337298B2
(en)
|
2013-10-18 |
2018-12-06 |
Indiana University Research And Technology Corporation |
Hepatitis B viral assembly effectors
|
JP6452119B2
(en)
|
2013-10-23 |
2019-01-16 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
Carboxamide derivatives and their use as pharmaceuticals for the treatment of hepatitis B
|
KR20160127714A
(en)
|
2013-11-14 |
2016-11-04 |
노비라 테라퓨틱스, 인코포레이티드 |
Azepane derivatives and methods of treating hepatitis b infections
|
JO3466B1
(en)
|
2013-12-20 |
2020-07-05 |
Takeda Pharmaceuticals Co |
Tetrahydropyridopyrazines modulators of gpr6
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
RU2692258C2
(en)
|
2014-01-31 |
2019-06-24 |
Когнишн Терапьютикс, Инк. |
Isoindoline compositions and methods of treating neurodegenerative disease
|
WO2015120178A1
(en)
|
2014-02-05 |
2015-08-13 |
Novira Therapeutics, Inc. |
Combination therapy for treatment of hbv infections
|
UY35980A
(en)
|
2014-02-06 |
2015-08-31 |
Janssen Sciences Ireland Uc |
DERIVATIVES OF SULFAMOILPIRROLAMIDA AS INHIBITORS OF HBV AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
JP6306750B2
(en)
|
2014-03-07 |
2018-04-04 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Novel 6-fused heteroaryl dihydropyrimidines for the treatment and prevention of hepatitis B virus infection
|
RS59430B1
(en)
|
2014-03-13 |
2019-11-29 |
Univ Indiana Res & Tech Corp |
Hepatitis b core protein allosteric modulators
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
SG11201605896WA
(en)
|
2014-03-28 |
2016-08-30 |
Sunshine Lake Pharma Co Ltd |
Dihydropyrimidine compounds and their application in pharmaceuticals
|
BR112016028000B1
(en)
|
2014-05-30 |
2022-05-17 |
Qilu Pharmaceutical Co., Ltd |
Loop derivative of dihydropyrimide as an hbv inhibitor
|
AU2015358561A1
(en)
|
2014-12-02 |
2017-06-08 |
Novira Therapeutics, Inc. |
Sulfide alkyl and pyridyl reverse sulfonamide compounds for HBV treatment
|
US9518057B2
(en)
|
2014-12-30 |
2016-12-13 |
Novira Therapeutics, Inc. |
Derivatives and methods of treating hepatitis B infections
|
MA41338B1
(en)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Pyrazine compounds for the treatment of infectious diseases
|
CA2980298A1
(en)
|
2015-03-19 |
2016-09-22 |
Novira Therapeutics, Inc. |
Azocane and azonane derivatives and methods of treating hepatitis b infections
|
WO2016161268A1
(en)
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
CN107922377A
(en)
|
2015-04-17 |
2018-04-17 |
美国印第安纳大学研究和技术公司 |
Hepatitis B assembles effector
|
WO2016183266A1
(en)
|
2015-05-13 |
2016-11-17 |
Enanta Pharmaceuticals, Inc. |
Ehpatitis b antiviral agents
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
CN108430971A
(en)
|
2015-09-29 |
2018-08-21 |
诺维拉治疗公司 |
The crystal form of B type hepatitis antivirus agent
|
SG11201808949SA
(en)
|
2016-04-15 |
2018-11-29 |
Novira Therapeutics Inc |
Combinations and methods comprising a capsid assembly inhibitor
|
CN109251212A
(en)
|
2017-07-14 |
2019-01-22 |
上海长森药业有限公司 |
Inner ring sulfide amide-arylamides and its purposes for treating hepatitis B
|
CR20200378A
(en)
*
|
2018-03-14 |
2021-01-08 |
Janssen Sciences Ireland Unlimited Co |
Capsid assembly modulator dosing regimen
|
CN113557016A
(en)
*
|
2019-03-13 |
2021-10-26 |
爱尔兰詹森科学公司 |
Capsid assembly regulator solid formulations
|
EP3955917A1
(en)
*
|
2019-04-18 |
2022-02-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
US20200332297A1
(en)
*
|
2019-04-18 |
2020-10-22 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
WO2020255012A1
(en)
*
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivatives
|